Portrait of Kurtis Auguste
ucsf logobch logo

Kurtis Auguste, MD

Pediatric Neurosurgery • Neurosurgery
Portrait of Kurtis Auguste
Portrait of Kurtis Auguste
ucsf logobch logo

Kurtis Auguste, MD

Pediatric Neurosurgery • Neurosurgery

On this page

About me

Dr. Kurtis Auguste is a pediatric neurosurgeon who specializes in disorders of the brain, peripheral nerves and spinal cord in children. He treats brain and spinal cord tumors, disorders of the brain's blood vessels, disorders involving the skull and face, epilepsy, hydrocephalus, neurotrauma (sudden head or spinal injuries), spasticity (ongoing muscle contraction from brain or spinal cord damage) and spinal dysraphism (a category of birth defects).

In research, Auguste focuses on epilepsy and neuronal migration disorders, birth defects that occur when nerve cells have not moved into the proper parts of the brain during fetal development.

Auguste earned his medical degree and completed a residency in neurosurgery at UCSF. He completed a fellowship in pediatric neurosurgery at the Hospital for Sick Children in Toronto.

Auguste is a member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.

Education & training

Board certification

  • Neurological Surgery, American Board of Neurological Surgery

Fellowship

  • Pediatric Neurosurgery, Hospital for Sick Children, University of Toronto

Residency

  • Neurosurgery, UCSF Graduate Medical Education

Internship

  • General Surgery, UCSF Graduate Medical Education

Degree

  • MD, UCSF School of Medicine

My expertise

My work

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.